CDK6 binds and promotes the degradation of the EYA2 protein

Cell Cycle

Volumn 13, Issue 1, 2014, Pages 62-71

  Kohrt, Dawn ^a   Crary, Jennifer ^a,b   Zimmer, Marc ^a   Patrick, Aaron N ^c   Ford, Heide L ^c   Hinds, Philip W ^b   Grossel, Martha J ^a  

^a The Holleran Center for Community Action and Public Policy   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Cdk6; Cell cycle; Degradation; EYA2; Progenitor cell; Proliferation

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CYCLIN DEPENDENT KINASE 6; CYCLOHEXIMIDE; DROSOPHILA PROTEIN; EYA PROTEIN; EYA2 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; ENZYME ACTIVITY; ESSENTIAL GENE; HUMAN; HUMAN CELL; NEOPLASM; NONHUMAN; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY;

CANCER; CDK6; CELL CYCLE; DEGRADATION; EYA2; PROGENITOR CELL; PROLIFERATION;

CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE 6; G1 PHASE; HEK293 CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOPLASMS; NUCLEAR PROTEINS; PROTEIN TYROSINE PHOSPHATASES; PROTEOLYSIS;

EID: 84892571196     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.26755     Document Type: Article

References (42)

1. Hu MG, Deshpande A, Enos M, Mao D, Hinds EA, Hu GF, Chang R, Guo Z, Dose M, Mao C, et al. A requirement for Cyclin-dependent kinase 6 in thymocyte development and tumorigenesis. Cancer Res 2009; 69: 810-8; PMID:19155308; http://dx.doi.org/10.1158/0008-5472.CAN-08-2473
2. Malumbres M, Sotillo R, Santamaría D, Galán J, Cerezo A, Ortega S, Dubus P, Barbacid M. Mammalian cells cycle without the D-type Cyclindependent kinases Cdk4 and Cdk6. Cell 2004; 118: 493-504; PMID:15315761; http://dx.doi.org/10.1016/j.cell.2004.08.002 (Pubitemid 39485668)
3. Matushansky I, Radparvar F, Skoultchi AI. Reprogramming leukemic cells to terminal differentiation by inhibiting specific Cyclin-dependent kinases in G1. Proc Natl Acad Sci U S A 2000; 97:14317-22; PMID:11114185; http://dx.doi.org/ 10.1073/pnas.250488697 (Pubitemid 32016573)
4. Matushansky I, Radparvar F, Skoultchi AI. Manipulating the onset of cell cycle withdrawal in differentiated erythroid cells with Cyclin-dependent kinases and inhibitors. Blood 2000; 96: 2755-64; PMID:11023509
5. Ericson KK, Krull D, Slomiany P, Grossel MJ. Expression of Cyclin-dependent kinase 6, but not Cyclin-dependent kinase 4, alters morphology of cultured mouse astrocytes. Mol Cancer Res 2003; 1: 654-64; PMID:12861051 (Pubitemid 36870518)
6. Ogasawara T, Katagiri M, Yamamoto A, Hoshi K, Takato T, Nakamura K, Tanaka S, Okayama H, Kawaguchi H. Osteoclast differentiation by RANKL requires NF-κB-mediated downregulation of Cyclin-dependent kinase 6 (Cdk6). J Bone Miner Res 2004; 19: 1128-36; PMID:15176996; http://dx.doi.org/10.1359/jbmr.2004. 19.7.1128 (Pubitemid 41110565)
7. Ogasawara T, Kawaguchi H, Jinno S, Hoshi K, Itaka K, Takato T, Nakamura K, Okayama H. Bone morphogenetic protein 2-induced osteoblast differentiation requires Smad-mediated downregulation of Cdk6. Mol Cell Biol 2004; 24:6560-8; PMID:15254224; http://dx.doi.org/10.1128/MCB.24.15.6560-6568.2004 (Pubitemid 38944337)
8. Fujimoto T, Anderson K, Jacobsen SE, Nishikawa SI, Nerlov C. Cdk6 blocks myeloid differentiation by interfering with Runx1 DNA binding and Runx1-C/EBPα interaction. EMBO J 2007; 26:2361-70; PMID:17431401; http://dx.doi.org/10.1038/sj.emboj.7601675 (Pubitemid 46685857)
9. Hu MG, Deshpande A, Schlichting N, Hinds EA, Mao C, Dose M, Hu GF, Van Etten RA, Gounari F, Hinds PW. CDK6 kinase activity is required for thymocyte development. Blood 2011; 117:6120-31; PMID:21508411; http://dx.doi.org/10.1182/ blood-2010-08-300517
10. Grossel MJ, Hinds PW. From cell cycle to differentiation: an expanding role for cdk6. Cell Cycle 2006; 5: 266-70; PMID:16410727; http://dx.doi.org/10. 4161/cc.5.3.2385 (Pubitemid 43213495)
11. Kollmann K, Heller G, Schneckenleithner C, Warsch W, Scheicher R, Ott RG, Schäfer M, Fajmann S, Schlederer M, Schiefer AI, et al. A Kinase-Independent Function of CDK6 Links the Cell Cycle to Tumor Angiogenesis. Cancer Cell 2013; 24:167-81; PMID:23948297; http://dx.doi.org/10.1016/j.ccr. 2013.07.012
12. Anders L, Ke N, Hydbring P, Choi YJ, Widlund HR, Chick JM, Zhai H, Vidal M, Gygi SP, Braun P, et al. A systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells. Cancer Cell 2011; 20:620-34; PMID:22094256; http://dx.doi.org/10.1016/j.ccr.2011.10.001
13. Laman H, Funes JM, Ye H, Henderson S, Galinanes-Garcia L, Hara E, Knowles P, McDonald N, Boshoff C. Transforming activity of Fbxo7 is mediated specifically through regulation of Cyclin D/cdk6. EMBO J 2005; 24: 3104-16; PMID:16096642; http://dx.doi.org/10.1038/sj.emboj.7600775 (Pubitemid 41486346)
14. Malumbres M, Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 2009; 9: 153-66; PMID:19238148; http://dx.doi.org/10. 1038/nrc2602
15. Tadjuidje E, Hegde RS. The Eyes Absent proteins in development and disease. Cell Mol Life Sci 2013; 70: 1897-913; PMID:22971774
16. Zhang L, Yang N, Huang J, Buckanovich RJ, Liang S, Barchetti A, Vezzani C, O'Brien-Jenkins A, Wang J, Ward MR, et al. Transcriptional coactivator Drosophila eyes absent homologue 2 is up-regulated in epithelial ovarian cancer and promotes tumor growth. Cancer Res 2005; 65: 925-32; PMID:15705892 (Pubitemid 40216453)
17. Wu K, Li Z, Cai S, Tian L, Chen K, Wang J, Hu J, Sun Y, Li X, Ertel A, et al. EYA1 phosphatase function is essential to drive breast cancer cell proliferation through Cyclin D1. Cancer Res 2013; 73: 4488-99; PMID:23636126; http://dx.doi.org/10.1158/0008-5472.CAN-12-4078
18. Sun J, Karoulia Z, Wong EY, Ahmed M, Itoh K, Xu PX. The phosphatase-transcription activator EYA1 is targeted by anaphase-promoting complex/Cdh1 for degradation at M-to-G1 transition. Mol Cell Biol 2013; 33: 927-36; PMID:23263983; http://dx.doi.org/10.1128/MCB.01516-12
19. Farabaugh SM, Micalizzi DS, Jedlicka P, Zhao R, Ford HL. Eya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-β signaling, epithelial-mesenchymal transition, and cancer stem cell properties. Oncogene 2012; 31:552-62; PMID:21706047
20. Pandey RN, Rani R, Yeo EJ, Spencer M, Hu S, Lang RA, Hegde RS. The Eyes Absent phosphatasetransactivator proteins promote proliferation, transformation, migration, and invasion of tumor cells. Oncogene 2010; 29: 3715-22; PMID:20418914; http://dx.doi.org/10.1038/onc.2010.122
21. Patrick AN, Cabrera JH, Smith AL, Chen XS, Ford HL, Zhao R. Structure-function analyses of the human SIX1-EYA2 complex reveal insights into metastasis and BOR syndrome. Nat Struct Mol Biol 2013; 20: 447-53; PMID:23435380; http://dx.doi.org/10.1038/nsmb.2505
22. Bierkens M, Krijgsman O, Wilting SM, Bosch L, Jaspers A, Meijer GA, Meijer CJ, Snijders PJ, Ylstra B, Steenbergen RD. Focal aberrations indicate EYA2 and hsa-miR-375 as oncogene and tumor suppressor in cervical carcinogenesis. Genes Chromosomes Cancer 2013; 52: 56-68; PMID:22987659; http://dx.doi.org/10.1002/gcc.22006
23. Wang QF, Wu G, Mi S, He F, Wu J, Dong J, Luo RT, Mattison R, Kaberlein JJ, Prabhakar S, et al. MLL fusion proteins preferentially regulate a subset of wild-type MLL target genes in the leukemic genome. Blood 2011; 117: 6895-905; PMID:21518926; http://dx.doi.org/10.1182/blood-2010-12-324699
24. Grossel MJ, Wang H, Gadea B, Yeung W, Hinds PW. A yeast 2-hybrid system for discerning differential interactions using multiple baits. Nat Biotechnol 1999; 17: 1232-3; PMID:10585727; http://dx.doi.org/10.1038/70792
25. van den Heuvel S, Harlow E. Distinct roles for Cyclin-dependent kinases in cell cycle control. Science 1993; 262: 2050-4; PMID:8266103; http://dx.doi.org/10.1126/science.8266103 (Pubitemid 24041887)
26. Kohrt DM, Crary JI, Gocheva V, Hinds PW, Grossel MJ. Distinct subcellular distribution of Cyclin dependent kinase 6. Cell Cycle 2009; 8:2837-43; PMID:19667758; http://dx.doi.org/10.4161/cc.8.17.9521
27. Meyerson M, Enders GH, Wu CL, Su LK, Gorka C, Nelson C, Harlow E, Tsai LH. A family of human cdc2-related protein kinases. EMBO J 1992; 11: 2909-17; PMID:1639063
28. Grossel MJ, Baker GL, Hinds PW. cdk6 can shorten G(1) phase dependent upon the N-terminal INK4 interaction domain. J Biol Chem 1999; 274:29960-7; PMID:10514479; http://dx.doi.org/10.1074/jbc.274.42.29960
29. Buller C, Xu X, Marquis V, Schwanke R, Xu PX. Molecular effects of Eya1 domain mutations causing organ defects in BOR syndrome. Hum Mol Genet 2001; 10: 2775-81; PMID:11734542; http://dx.doi.org/10.1093/hmg/10.24.2775 (Pubitemid 34026459)
30. Ohto H, Kamada S, Tago K, Tominaga SI, Ozaki H, Sato S, Kawakami K. Cooperation of six and eya in activation of their target genes through nuclear translocation of Eya. Mol Cell Biol 1999; 19: 6815-24; PMID:10490620 (Pubitemid 29441865)
31. Patrick AN, Schiemann BJ, Yang K, Zhao R, Ford HL. Biochemical and functional characterization of six SIX1 Branchio-oto-renal syndrome mutations. J Biol Chem 2009; 284: 20781-90; PMID:19497856; http://dx.doi.org/10.1074/jbc. M109.016832
32. Bloom J, Pagano M. Experimental tests to definitively determine ubiquitylation of a substrate. Methods Enzymol 2005; 399: 249-66; PMID:16338361; http://dx.doi.org/10.1016/S0076-6879(05)99017-4 (Pubitemid 41772734)
33. Xiong W, Dabbouseh NM, Rebay I. Interactions with the Abelson tyrosine kinase reveal compartmentalization of eyes absent function between nucleus and cytoplasm. Dev Cell 2009; 16: 271-9; PMID:19217428; http://dx.doi.org/10.1016/j. devcel.2008.12.005
34. Guo JT, Ding LH, Liang CY, Zhou NK, Ye QN. [Expression of EYA2 in non-small cell lang cancer]. Zhonghua Zhong Liu Za Zhi 2009; 31: 528-31; PMID:19950702
35. Raychaudhuri P, Park HJ. FoxM1: a master regulator of tumor metastasis. Cancer Res 2011; 71: 4329-33; PMID:21712406; http://dx.doi.org/10.1158/0008- 5472.CAN-11-0640
36. Christensen KL, Brennan JD, Aldridge CS, Ford HL. Cell cycle regulation of the human Six1 homeoprotein is mediated by APC(Cdh1). Oncogene 2007; 26: 3406-14; PMID:17130831; http://dx.doi.org/10.1038/sj.onc.1210122 (Pubitemid 46788881)
37. Ford HL, Landesman-Bollag E, Dacwag CS, Stukenberg PT, Pardee AB, Seldin DC. Cell cycleregulated phosphorylation of the human SIX1 homeodomain protein. J Biol Chem 2000; 275: 22245-54; PMID:10801845; http://dx.doi.org/10.1074/jbc. M002446200 (Pubitemid 30621807)
38. Chang G, Guida C, Still WC. An internal-coordiante monte carlo method for searching conformational space. J Am Chem Soc 1989; 111: 4379-86; http://dx.doi.org/10.1021/ja00194a035
39. Klossvary I, Keseru GM. Hessian-free low-mode conformational search for large-scale protein loop optimization: Application to c-jun N-terminal kinase JNK3. J Comput Chem 2001; 22: 21-30; http://dx.doi.org/10.1002/1096- 987X(20010115)22:1<21::AIDJCC3> 3.0.CO;2-I (Pubitemid 33645647)
40. Saunders M, Houk K, Wu Y-D. Conformations of cycloheptadecane. A comparison of methods for confomational searching. J Am Chem Soc 1990; 112:1419; http://dx.doi.org/10.1021/ja00160a020
41. Embry AC, Glick JL, Linder ME, Casey PJ. Reciprocal signaling between the transcriptional co-factor Eya2 and specific members of the Galphai family. Mol Pharmacol 2004; 66: 1325-31; PMID:15308761; http://dx.doi.org/10.1124/mol.104. 004093 (Pubitemid 39411073)
42. Fan X, Brass LF, Poncz M, Spitz F, Maire P, Manning DR. The alpha subunits of Gz and Gi interact with the eyes absent transcription cofactor Eya2, preventing its interaction with the six class of homeodomain-containing proteins. J Biol Chem 2000; 275: 32129-34; PMID:10906137; http://dx.doi.org/10. 1074/jbc.M004577200